image
Eton Pharmaceuticals, Inc. ETON
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 10.02
-4.21 %
$ 259 M
Market Cap
-38.54
P/E
INCOME STATEMENT
31.6 M REVENUE
48.90%
Growth Rates
1Year 48.90%
3Years 832.68%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-1.19 M OPERATING INCOME
85.57%
Growth Rates
1Year 85.57%
3Years 64.71%
5Years 35.06%
7Years 0.00%
10Years 0.00%
-936 K NET INCOME
89.62%
Growth Rates
1Year 89.62%
3Years 67.77%
5Years 40.68%
7Years 0.00%
10Years 0.00%
EFFICIENCY
Earnings Waterfall Eton Pharmaceuticals, Inc.
image
Revenue 31.6 M
Cost Of Revenue 10.6 M
Gross Profit 21.1 M
Operating Expenses 22.3 M
Operating Income -1.19 M
Other Expenses -256 K
Net Income -936 K

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
REVENUE
Revenue 31.6 21.3 21.8 39 K 1.0 0 0
GROSS PROFIT
Cost Of Revenue 10.6 6.9 2.6 0.3 0.5 63 K 13 K
Gross Profit 21.1 14.3 19.2 (0.2) 0.5 63 K 13 K
OPERATING INCOME
Operating Expenses 22.3 22.6 20.7 26.9 19.1 10.3 7.1
Selling, General and Administrative Expenses 18.9 18.6 14.5 12.8 7.6 4.7 3.2
Research and Development Expenses 3.3 4.0 6.2 14.1 11.6 5.6 3.9
Operating Income (1.2) (8.3) (1.5) (27.1) (18.6) (10.3) (7.2)
PRE-TAX INCOME
Interest Income Expense 0 1.0 1.0 0.9 0 0 0
Total Other Income 0.5 (0.8) (0.5) (0.9) 0.3 (2.4) 6 K
Pre-Tax Income (0.7) (9.0) (2.0) (28.0) (18.3) (12.7) (7.2)
NET INCOME
Tax Provision 0.2 0.8 1.0 0.9 (0.3) (2.6) 0
Net Income (0.9) (9.8) (3.0) (28.8) (18.0) (12.7) (7.2)
EPS 0.0365 0.39 0.12 1.37 1.02 1.99 0.41